Search research articles
Contact Us
Filters
Showing results (41-50 of 210) with videos related to
Page
of 21
Sort By:
British Journal of Haematology
|
March 27, 2024
Management of vaccinations in patients with non-Hodgkin lymphoma
Michele Merli, Andrea Costantini, Silvio Tafuri, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
April 21, 2025
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy
Stefano Luminari, Antonio Pinto, Benedetta Puccini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 29, 2024
Identifying unmet needs in cancer survivorship by linking patient-reported outcome measures to the International Classification of Functioning, Disability and Health
Margherita Schiavi, Stefania Costi, Irene Barbieri, et al.
Hematological Oncology
|
April 30, 2014
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry
Irene Biasoli, Marina Cesaretti, Monica Bellei, et al.
Cancers
|
July 2, 2021
Indolent T-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract (iTLPD-GI): A Review
Francesca Sanguedolce, Magda Zanelli, Maurizio Zizzo, et al.
BMC Cancer
|
November 8, 2018
The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
Enza Di Felice, Francesca Roncaglia, Francesco Venturelli, et al.
Hematological Oncology
|
January 25, 2012
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy
Paolo G Gobbi, Emilio Bassi, Manuela Bergonzi, et al.
Hematological Oncology
|
September 23, 2025
A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection
Monia Marchetti, Paolo Corradini, Luca Arcaini, et al.
British Journal of Haematology
|
June 5, 2003
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasias
Stefano Luminari, Maria Goldaniga, Fulvia Ceccherelli, et al.
Hematological Oncology
|
November 20, 2020
Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin's and diffuse large B-cell lymphoma
Benedetta Donati, Angela Ferrari, Alessia Ruffini, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 210) with videos related to
Sort By:
Page
of 21
British Journal of Haematology
|
March 27, 2024
Management of vaccinations in patients with non-Hodgkin lymphoma
Michele Merli, Andrea Costantini, Silvio Tafuri, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
April 21, 2025
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy
Stefano Luminari, Antonio Pinto, Benedetta Puccini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 29, 2024
Identifying unmet needs in cancer survivorship by linking patient-reported outcome measures to the International Classification of Functioning, Disability and Health
Margherita Schiavi, Stefania Costi, Irene Barbieri, et al.
Hematological Oncology
|
April 30, 2014
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry
Irene Biasoli, Marina Cesaretti, Monica Bellei, et al.
Cancers
|
July 2, 2021
Indolent T-Cell Lymphoproliferative Disorders of the Gastrointestinal Tract (iTLPD-GI): A Review
Francesca Sanguedolce, Magda Zanelli, Maurizio Zizzo, et al.
BMC Cancer
|
November 8, 2018
The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
Enza Di Felice, Francesca Roncaglia, Francesco Venturelli, et al.
Hematological Oncology
|
January 25, 2012
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy
Paolo G Gobbi, Emilio Bassi, Manuela Bergonzi, et al.
Hematological Oncology
|
September 23, 2025
A SWOT-Consensus for CAR-T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection
Monia Marchetti, Paolo Corradini, Luca Arcaini, et al.
British Journal of Haematology
|
June 5, 2003
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasias
Stefano Luminari, Maria Goldaniga, Fulvia Ceccherelli, et al.
Hematological Oncology
|
November 20, 2020
Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin's and diffuse large B-cell lymphoma
Benedetta Donati, Angela Ferrari, Alessia Ruffini, et al.
Page
of 21